ELISA analysis of tumour homogenates demonstrated significantly higher TNFα levels within tumours of MG-TNFα treated mice compared with controls (mice i.v. administered engineered MG1655 lacking the TNFα gene or PBS) (Fig 4A). The gene discussed is TNF; the disease is neoplasm.